Literature DB >> 164521

Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.

W E Stewart II, P De Somer, V G Edy, K Paucker, K Berg, C A Ogburn.   

Abstract

Human fibroblast interferon preparations were completely stabilized to 100 degrees C by sodium dodecyl sulphate (SDS) in the presence of mercaptoethanol, but only a minor fraction of their activities were stabilized by SDS without mercaptoethanol. On the contarary, human leukocyte interferon preparations were completely stabilized to 100 degrees C by SDS in the absence of mercaptoethanol, but only a minor fraction of their activities were stabilized by SDS in the presence of mercaptoethanol. Furthermore, human fibroblast interferon preparations whose activities had been destroyed by boiling at 100 degrees C were completely reactivated by SDS under reducing conditions, but only a minor part of their activities were restored by SDS in the absence of reduction. On the contrary, human leukocyte interferon preparations whose activities had been destroyed by boiling at 100 degrees C were completely reactivated by SDS in the absence of reduction, but only a minor part of their activities were restored by SDS under reducing conditions. These data suggest that there are distinct molecular species of human interferons.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164521     DOI: 10.1099/0022-1317-26-3-327

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.

Authors:  W E Stewart; L S Lin; M Wiranowska-Stewart; K Cantell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Stable and unstable forms of human fibroblast interferon.

Authors:  V G Edy; J Desmyter; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Purification and partial characterization of human lymphoblast interferon.

Authors:  K C Zoon; M E Smith; P J Bridgen; D zur Nedden; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 5.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  Multiple active sites on human interferons.

Authors:  K Paucker; B J Dalton; C A Ogburn; E Törmä
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

7.  Human nasal epithelial cell culture system: evaluation of response to human interferons.

Authors:  M W Harmon; S B Greenberg; P E Johnson; R B Couch
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  The reactivation of human interferons by guanidine thiocyanate.

Authors:  R J Jariwalla; J J Sedmak; S E Grossberg
Journal:  Experientia       Date:  1980-12-15

9.  Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model.

Authors:  D Neumann-Haefelin; R Sundmacher; R Skoda; K Cantell
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  Human fibroblast interferon for clinical trials: production, partial purification, and characterization.

Authors:  A Billiau; J V Damme; F V Leuven; V G Edy; M De Ley; J J Cassiman; H Van de Berghe; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.